Abstracts, reviews, editorials, and other articles without original data were also excluded
Florida Blue is a member of the Blue Cross Blue Shield Association based in Florida
The measured semaglutide content substantially exceeded the labeled amount in each sample by 29% to 39%, meaning that users could receive up to 39% more semaglutide per injection
Gastrointestinal symptomsparticularly nausea, vomiting, diarrhoea, and constipationare the most frequently reported adverse effects of GLP-1 receptor agonists, occurring in 2050% of patients depending on the specific agent and dose according to clinical trials and SmPC data
[17] [15] For those using GLP-1 medications for diabetes management , discontinuation often results in worsening glycaemic control
Women of the overweight/obese group were the youngest (median age 32 years) followed by those of GLP1-RA group (median age 34 years)